Seqens Seqens

X

Find Radio Compass News for DSSTox_CID_3146

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
24
INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

USP

JP

0

Other Listed Suppliers

SERVICES

0

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-01-2022-1654158193.pdf

FDA
01 Jun 2022

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-17-2021-1637135168.pdf

FDA
17 Nov 2021

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-14-2019-1565765849.pdf

FDA
14 Aug 2019

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-19-2019-1560925761.pdf

FDA
19 Jun 2019

https://www.pharmacompass.com/pdf/news/pharm-d-solutions-llc-issues-voluntary-nationwide-recall-of-all-sterile-compounded-drugs-due-to-a-potential-lack-of-sterility-assurance-1558768382.pdf

FDA
23 May 2019

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-8-2019-1557294096.pdf

FDA
08 May 2019

https://www.pharmacompass.com/pdf/news/inventive-infusion-solutions-receives-fda-form-483-1538036934.pdf

FDA
27 Sep 2018

https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-May-3-2017-1493786253.pdf

FDA
03 May 2017
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY